Shustik, Jesse. 2025. “Unique Toxicities of Novel Myeloma Therapies: Focus on Belantamab Mafodotin, Talquetamab, and Selinexor”. Canadian Hematology Today 4 (3). Toronto, Canada:24–35. https://doi.org/10.58931/cht.2025.4379.